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which were used daily during radiotherapy and for 6 months after the conclusion of the 
treatment. In addition, a fourth group, composed by 15 additional oncologic patients, who 
did not receive the mouthwash or initial dental treatment, constituted the control group. 
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treatment, immediately before radiotherapy, after radiotherapy and 30, 60, 90 days and 6 
months after the conclusion of radiotherapy. After clinical examinations, samples of saliva 
were inoculated on SB20 selective agar and incubated under anaerobiosis, at 37
oC for 48 
h. Total mutans streptococci counts were also evaluated by using real-time PCR, through 
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of radiotherapy side effects, such as mucositis and candidosis. Conclusion: These results 
highlights the importance of the initial dental treatment for patients who will be subjected 
to radiotherapy for head and neck cancer treatment.
Key words: Radiotherapy. Streptococcus mutans. Dental caries.
INTRODUCTION
Treatment of head and neck cancer (HNC) 
consists of surgery, radiotherapy (RT), and the 
association between them, besides the use of 
chemotherapy as an adjuvant in the treatment14. 
However, radiotherapy has been associated with 
several side effects, such as mucositis, changes 
in salivary gland function, radiation caries and 
especially osteoradionecrosis of the jaws2,23. 
These undesirable effects may affect treatment 
evolution and patient compliance with treatment. 
The occurrence of these reactions depends on 
the radiation dose, volume of irradiated tissue, 
fraction size, fractionation scheme, type of 
ionizing radiation, location of the irradiated area 
and other concomitant treatments23. In addition, 
individual aspects including age, systemic 
status, oral hygiene habits, tobacco and alcohol 
consumption2 also need to be considered.
The occurrence of radiation caries and 
mucositis is high as 40-100% of the irradiated 
www.scielo.br/jaos
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patients22,23, producing extreme discomfort and 
compromising the acceptance15, continuity21 and 


	>)7. Salivary gland dysfunction 
induced by RT results in hyposalivation, which 
may change the oral microbiota to a highly 
cariogenic microbiota, decrease clearance of 
carbohydrates from diet and organic acids 
produced by microorganisms, reduce buffering 
capacity, and impair remineralization of the tooth 
structure9,18.
In addition, patients who have xerostomia may 
consume a diet of soft, carbohydrate-rich foods, 
which may further increase the susceptibility to 
dental caries. Taken together, these changes may 
lead to rampant caries after RT6,20. In Brazil, three 
preventive schemes are followed by most of the 
radiotherapy centers for prevention of radiation 
caries and osteoradionecrosis: chlorhexidine 
gluconate (0.12%), sodium fluoride (0.5%, 
aqueous solution) and sodium iodine (2% in 
hydrogen peroxide 10 v/v). However, there are 
no microbiological evidences that these protocols 
are effective when associated to the oral hygiene, 
especially in a population composed mainly by 
people with low socioeconomic level. 
Thus, the aim of this study was to evaluate 
the influence of these preventive protocols 
associated to the improvement of oral hygiene 
standards on mutans streptococci counts in 60 
patients submitted to radiotherapy for treatment 
of head and neck cancer.
MATERIAL AND METHODS
Population
A total of 60 patients seen at the Department 
of Dentistry of the Barretos Cancer Hospital, SP, 
Brazil and the Megavoltage Radiotherapy Center, 
SP, Brazil, comprising 52 males and 8 females, 
aged 18-63 years (mean age 49.75 years), with 
histopathological diagnosis of malignant disease 
were included in this longitudinal study. Fifty 
patients presented squamous cell carcinoma, 
three with adenocarcinoma, six with Hodgkin 
lymphoma and one patient harbored liposarcoma. 
All patients gave written informed consent to 
be recruited for this study, which was approved 
by the Research and Ethics Committee of the 
School of Dentistry of Araçatuba, São Paulo 
State University - UNESP (Proc. 136/2007). 
All patients had at least ten teeth after initial 
dental treatment (IDT) and were able to comply 
with the preventive clinical protocols. Patients 
with previous diagnosis of HIV infection, use 
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cardiovascular, pulmonary, renal or hepatic 
disease were excluded.
Prior to radiotherapy, patients were separated 
randomly into four different groups:
Group I: patients were submitted to initial 
dental treatment (IDT), generally 3-4 weeks 
before RT, which consisted of extractions, 
restorations, scaling, and dental prophylaxis. 
These patients were instructed to use 
chlorhexidine gluconate (0.12%) once daily for 
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6 months after conclusion of the treatment. Oral 
hygiene instructions were reinforced at each 
visit;
Group II: after IDT, patients used sodium 
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hygiene instructions were reinforced at each 
visit;
Group III: after IDT, the patients used 
sodium iodine (2% in hydrogen peroxide 10 v/v) 
once daily and oral hygiene instructions were 
reinforced at each visit;
Group IV: patients received no preventive 
dental treatment. It is important to highlight 
that they received no oral hygiene instructions 
before RT. Patients of this group were instructed 
by the oncologists to look for professional care 
in public dental clinics, but no one did it. They 
received medical treatment with no odontological 
assistance and received oral hygiene instructions 
only during and after RT.
The mean radiation dose received by the 
patients varied from 5.040 to 7.020 cGy, and the 
fractioning dose was 180 cGy. RT was carried out 
using a linear accelerator. 
Clinical procedures
In groups I, II or III, clinical examinations 
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hygiene instructions (stage 1), immediately after 
IDT (stage 2), before RT (stage 3), immediately 
after RT (stage 4), 30 days (stage 5), 60 days 
(stage 6), 90 days after RT (stage 7) and 6 
months after RT (stage 8). The oral hygiene 
status was assessed using the plaque index 
(PI)19. In group IV, clinical examinations were 
performed just before RT, 3 weeks after the 
beginning of RT, immediately after, 30 days and 
6 months after RT. 
Collection of clinical samples, microbial 
isolation and enumeration
Whole resting saliva was collected from each 
patient before IDT, immediately after IDT, before 
RT, immediately after RT, 30, 60, 90 days and 
6 months after RT, for mutans streptococci 
enumeration. Saliva was collected through the 
draining method; patients were placed in a quiet 
room, asked not to drink, eat or clean their 
mouths 1 h before saliva collection and instructed 
not to swallow any saliva during the collection 
period3. Test tubes containing the samples were 
immediately placed in a refrigerator (for culture) 
or liquid nitrogen (real-time PCR).
Laboratory processing was performed within 
2 h. After mechanical mixing, samples were 
serially diluted and plated on selective SB20 agar, 
incubated anaerobically (90% N2 + 10% CO2), 
for 48 hours, at 37oC, for mutans streptococci 
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out by means of bacteria and colony morphology 
analyses as well as biochemical tests. After 
evaluation of mutans streptococci counts by 
culture, the caries risk of each subject was 
determined24. 
	
 
  
	
		 
real-time PCR
)   *

 	



   + 

PCR. After extraction of bacterial DNA from saliva 
by QIAamp DNA Mini Kit (Qiagen, Duisburg, 
Germany), real-time PCR was carried out using 
a Rotor Gene 6000 (Corbett Life Science, Mort 
Lake, New South Wales, Australia). Each PCR was 
performed in duplicate using a total volume of 
25 μl, containing 12.5 μl 2X Taqman Universal 
Master Mix (Applied Biosystems), 0.2 μl each of 
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200 nM each), an appropriate concentration of 
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μl of template DNA solution and an appropriate 
volume of sterilized DNase-RNase-free water. 
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initial denaturation at 94oC for 10 min, 40 cycles 
at 95oC for 15 s and 60oC for 1 min. Primers 
were designed according to those described in 
literature for S. mutans and S. sobrinus25.
Statistical analysis
Statistical analysis was performed using 
the software Statistical Package for the Social 
Sciences (SPSS Inc., v.13, Chicago, IL, USA). 
Quantitative variables (mean and standard 
deviation) were analyzed with Student’s t-test. 
Multiple comparisons were carried out by means 
of Kruskall-Wallis test, while dichotomous 
variables were analyzed by Mann-Whitney, Chi-
square or Fisher’s exact tests. Difference of P 
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RESULTS
Unfortunately, out of the 60 patients initially 
examined, 10 did not conclude RT and 11 other 
patients were not in physical conditions to be 
submitted to final intra-oral examinations. 
Oral manifestations associated to radiotherapy 
are presented in Table 1. Before RT, oral 
mucositis and dermatitis were not observed. 
Erythematous candidosis was detected in one 
patient of group IV and xerostomia was reported 
by two patients (group II and group IV). After 
RT, mucositis, xerostomia, and dermatitis 
were widely disseminated, irrespective of the 
experimental group, and except for candidosis, 
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between groups regarding these side effects of 
RT.
In Group IV, immediately after RT, candidosis 
was diagnosed both in its pseudomembranous 
(two cases) and erythematous variants (six 
cases), while patients of the other groups 
presented only chronic erythematous candidosis. 
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higher in group IV (P= 0.031).
The incidence of RT side effects was reduced 
30 d after conclusion of the treatment, but 
occurrence of candidosis remained higher in 
group IV than in other groups. Six months 
after RT conclusion, xerostomia and mucositis 
constituted the most common alterations in the 
oral cavity, although their severity evidenced a 
mild reduction in most patients. In group IV, the 
reduction of mucositis and candidosis was slower 
than reported in other groups, and 77.78% of 
the patients presented this condition 6 months 
after RT. Moreover, in group IV, mucositis was 
statistically associated with xerostomia (P < 
0.001), while in the other groups xerostomia 
was restricted to approximately 30-40% of the 
patients, 6 months after RT. 
Xerostomia, dermatitis and mucositis were 
not prevented by any particular protocol, and all 
groups evidenced similar results (Table 1), while 
all preventive protocols reduced the occurrence 
of candidosis. It was also observed that in 
patients presenting clinical signs of mucositis 6 
month after RT conclusion, mucositis level I and 
II predominated; while immediately after RT, 
most patients harbored mucositis level II and, 
especially, level III. 
Initial plaque index values were very high 
in groups I, II, and III, ranging from 3.02 ± 
0.54 (group I) to 3.46 ± 0.98 (group II), with 
no significant differences between groups. 
However, there was a gradual reduction of these 
values over the clinical follow-up period and no 
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Clinical          Occurrence of radiotherapy side effects N (%) 
Condition      Before RT1     After RT2      30 d after RT3     6 months after RT4
Mucositis     
 Group I     0 (0.0)     12 (92.31)    8 (61.54)      4 (40.0) 
 Group II    0 (0.0)     10 (90.91)    7 (63.63)      3 (33.33) 
 Group III    0 (0.0)     11 (78.57)    8 (66.67)      4 (36.36) 
 Group IV    0 (0.0)     10 (83.33)    8 (72.73)      7 (77.78) 
Dermatitis     
 Group I    0 (0.0)     12 (92.31)    8 (61.54)      1 (10.0) 
 Group II    0 (0.0)     11 (100.0)    8 (88.89)      2 (22.22) 
 Group III    0 (0.0)     11 (78.57)    7 (63.64)      0 (0.0) 
 Group IV    1 (6.67)    12 (100.0)    7 (77.78)      2 (22.22) 
Candidosis     
 Group I    0 (0.0)     3 (23.08)    1 (7.69)      0 (0.0) 
 Group II    0 (0.0)     3 (27.27)    2 (18.18)      1 (9.09) 
 Group III    0 (0.0)     4 (28.57)    1 (8.33)      0 (0.0) 
 Group IV    1 (6.67)    8 (66.67)    5 (45.45)      3 (33.33) 
Xerostomia     
 Group I    0 (0.0)     12 (92.31)    10 (76.92)      8 (80.0) 
 Group II    1 (6.67)    11 (100.0)    10 (90.91)      6 (75.0) 
 Group III    0 (0.0)     12 (85.71)      9 (75.0)      7 (63.63) 
 Group IV    1 (6.67)    11 (91.67)      8 (72.73)      7 (77.78)
Table 1- Oral status of the experimental groups at different periods of analysis
1Number of patients in the different groups just before radiotherapy: Group I, N= 15; Group II, N= 15; Group III, N= 15; 
Group IV, N= 15. Total = 60.
2Number of patients in the different groups immediately after radiotherapy: Group I, N= 13; Group II, N= 11; Group III, N= 
14; Group IV, N= 12. Total = 50.
3Number of patients in the different groups 30 days after conclusion of radiotherapy: Group I, N= 13; Group II, N= 11; Group 
III, N= 12; Group IV, N= 11. Total= 47.
4Number of patients in the different groups 6 months after conclusion of radiotherapy: Group I, N= 10; Group II, N= 9; Group 
III, N= 11; Group IV, N= 9. Total= 39.
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Groups         Mean mutans streptococci counts x105 ± Standard deviations x105 
       Baseline1    before RT   after RT      30 d after RT       6 months 
                               after RT
Group I      
Culture2     8.7 ± 4.6    1.9 ± 3.7    2.3 ± 1.8    2.0 ± 0.56    7.5 ± 3.1
Real-time PCR3   11.4 ± 5.4    2.1 ± 4.8    2.9 ± 1.9    2.6 ± 0.7    9.2 ± 3.1
Group II      
Culture     16 ± 4.9    4.4 ± 3.7    5.7 ± 1.8    5.2 ± 2.9    9.8 ± 5.1
Real-time PCR   23 ± 12.5    5.1 ± 4.7    7.0 ± 5.6    7.9 ± 6.3    14 ± 11.3
Group III      
Culture     21 ± 9.2    12 ± 3.7    5.4 ± 5.1    15.8 ± 6.2    16.2 ± 3.8
Real-time PCR   37 ± 12    9 ± 8.3     6.7 ± 4.9    15.0 ± 3.1    18.8 ± 7.1
Group IV      
Culture     ____4     8.5 ± 4.8    18.7 ± 9.6    81 ± 41    77 ± 22.4
Real-time PCR           ____      7.8 ± 5.2    15.3 ± 13.4   123 ± 45.2   83 ± 24.5
1Immediately before dental treatment.
2CFU/mL.
3DNA copies/mL. Total S. mutans + S. sobrinus.
4Group IV: patients did not receive initial dental treatment.
Table 2- Mean counts of mutans streptococci in the experimental groups during the study
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Group I     
Before IDT     0 (0.0)     2 (13.33)      7 (46.67)     6 (40.0) 
Before RT      1 (6.67)    3 (20.0)      9 (60.0)     2 (13.33) 
After RT      0 (0.0)     4 (30.77)      9 (69.23)     0 (0.0) 
6 months after RT   0 (0.0)     3 (30.0)      4 (40.0)     3 (30.0) 
Group II     
Before IDT     0 (0.0)     0 (0.0)       8 (53.33)     7 (46.67) 
Before RT      2 (13.33)    3 (20.0)      9 (60.0)     1 (6.67) 
After RT      0 (0.0)     3 (27.27)      8 (72.72)     0 (0.0) 
6 months after RT   0 (0.0)     2 (22.22)      4 (44.44)     3 (33.33) 
Group III     
Before IDT     0 (0.0)     1 (6.67)      8 (53.33)     6 (40.0) 
Before RT      1 (6.67)    2 (13.33)      8 (53.33)     4 (26.67) 
After RT      0 (0.0)     0 (0.0)       10 (71.43)     4 (28.57) 
6 months after RT   0 (0.0)     2 (18.18)      5 (45.45)     4 (36.36) 
Group IV     
Before IDT     ___a      ___        ___       ___ 
Before RT      0 (0.0)     2 (.0)       8 (53.33)     5 (33.33) 
After RT      0 (0.0)     0 (0.0)       5 (41.67)     7 (41.67) 
6 months after RT   0 (0.0)     0 (0.0)       3 (33.33)     6 (66.67)
Table 3- Effects of preventive protocols on dental caries risk in irradiated patients. Results of mutans streptococci counts 
were obtained by culture
1Low risk, mutans streptococci counts <104 CFU/mL of saliva; moderate risk, mutans streptococci counts 104 - <105 CFU/
mL of saliva; high risk, mutans streptococci counts 105 - <106 CFU/mL of saliva; plaque overgrowth, mutans streptococci 
counts =106 CFU/mL of saliva;
a Group IV: patients did not receive initial dental treatment.
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groups I, II and III, while group IV showed 
3.25 ± 0.84 before RT and 2.86 ± 0.61, six 
months after RT treatment. Statistical analysis 
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reduction of dental plaque in groups I, II, and 
III (P= 0.0026), but in group IV the reduction 
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!P= 0.232). The 
improvement of oral hygiene standards was more 
pronounced just before and after RT, reinforcing 
the need for continuous follow-up.
In relation to mutans streptococci counts, 
they were very high at baseline, but initial dental 
treatment as well as all preventive protocols used 
during the study were able to reduce acidogenic 
cocci. The mutans streptococci counts are shown 
in Table 2. No statistical difference between values 
in each group was observed before RT, but the 
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of streptococci in group I (chlorhexidine) in 
comparison with group II (P= 0.03), group III 
(P=0.001) or group IV (P< 0.001). After the 
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higher counts of cariogenic cocci in relation to 
the other groups (P<0.001), evidencing the role 
of initial dental treatment in reducing cariogenic 
cocci. Comparison between groups II and III 
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(P= 0.9952).
At baseline, most patients of groups I, II 
and III were at high-risk for dental caries or 
presented microbial overgrowth on agar plates. 
There was a slight caries risk reduction after IDT 
and this phenomenon was sustained during RT, 
except for group IV (Table 3).
DISCUSSION
Dental caries risk is a serious problem for 
patients undergoing RT for head and neck 
cancer9,14,23. Carious lesions develop rapidly, 
and advanced destruction of the tooth structure 
can be observed as fast as several weeks or 
months after RT. Therefore, preventive measures 
before, during, and after RT are necessary 
and should include instructions regarding a 
noncariogenic diet, regular oral hygiene, and 
application of chemical compounds to prevent 
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loss of  the dental structures9. However, 
literature8,10 has shown that caries and cariogenic 
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and chlorhexidine application. In the present 
investigation, chlorhexidine produced the most 
noticeable changes in the cariogenic microbiota 
of the patients.
In the present study, most patients with 
head and neck cancer are middle aged adult 
males who were chronic tobacco and alcohol 
consumers and had advanced tumors located 
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In these patients, dental treatment before RT is 
necessary to avoid dental extractions and prevent 
osteoradionecrosis and other traumatic sequelae 
during and after RT2,16. This is particularly true 
for patients with low socioeconomic conditions 
who show poor oral hygiene status2.
At baseline, the population evaluated in this 
study presented an initial very high risk for 
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in levels of mutans streptococci was achieved 
especially in group I patients, the occurrence 
of new lesions of dental caries was observed in 
some patients of all groups, but especially in 
group IV. 
Patients with high-risk for dental caries who 
have medium to high levels of mutans streptococci 
should use an antibacterial mouthrinse11.
Currently, the most effective antibacterial 
mouthrinse against cariogenic bacteria is 
chlorhexidine. High-risk adults should rinse daily 
with 10 mL for 1 minute at bedtime for 1 week. 
This should be done for 1 week every month for 
up to 6 months. If used only 1 week per month, 
staining of the teeth and oral mucosa should 
be a minimal issue. Compliance is also a major 
issue with this product, which is why it should 
only be used for 1 week per month11. However, 
in the present study, all patients showed high 
risk for caries at baseline and this risk would 
obviously increase by irradiation, then the use 
of chlorhexidine was recommended during all 
the experiment.
The slight reduction in the levels of mutans 
streptococci observed in patients using sodium 
 ! __&   
 +
the direct antimicrobial activity of the chemical 
	
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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agent, but due to the inhibitory activity which it 
carries on the enzymes related to saccharolytic 
metabolism. This could represent an ecological 
disadvantage for acidogenic cocci, as many oral 
microorganisms adhere better to acidic pH. 
Thus, the reduction of carbohydrate fermentation 
may have contributed to the slight reduction of 




+

incidence, avoiding acidification of the oral 
environment.
)	 
 
 
has become standard practice in RT patients9, 
but as all preventive protocols, this protocol 
is very sensitive to patients’ compliance9. It 
has been estimated that patients must follow 
an application frequency of at least 70% to 
prevent decay13. However, compliance with 

+


with head and neck cancer is generally thought 
to be poor4,13,18  and this phenomenon may be 
due to the inconvenient method of application. 
/
     

+
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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for a longer period, our experience showed that 

*

compliance, thus this protocol was chosen.
Other compounds used until recently 
in the prevention of radiation caries and 
osteoradionecrosis, such as sodium iodide 
prepared in hydrogen peroxide have been 
discouraged due to their suspected carcinogenicity 


++


process5.
Many head and neck cancer patients have 
poor oral hygiene2,17 and patient adherence to 
the preventive protocols is closely correlated with 
follow-up visits6,9. Therefore, patient care must be 
individualized with evaluation at regular intervals 
to determine the caries risk and evolution, in 
order to preserve adequate oral health status9. In 
this study, patients were instructed to maintain 






	
this regimen probably interfered with patients’ 
 
  
 

clinical outcome of the preventive protocols.
After RT, no single case of osteoradionecrosis 
was observed, probably due the time span 
between teeth extractions and the beginning of 
RT23 in groups I, II and III, since wound healing 
during RT represents a high risk for the onset of 
osteoradionecrosis1,12. In group IV, due to lack 
of time for completion of the dental treatment, 
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The occurrence of new caries in the 
experimental groups was much lower than 
initially expected and, in spite of the fact 


  


 
  
identified between caries experience and 
history of fluoride, iodine or chlorhexidine 
use, all preventive protocols were considered 
effective in the prevention of radiation caries and 
osteoradionecrosis.
CONCLUSIONS
Chlorhexidine was the most efficient 
mouthrinse to reduce mutans streptococci in 
the saliva of head and neck cancer patients 
undergoing radiotherapy treatment; it also 
ameliorated oral mucositis and eliminated oral 
candidosis in the experimental groups. The 
results evidenced the great importance of the 
dental team and initial dental treatment as a 
measure to reduce the severity and extension 
of radiotherapy side effects in the oral cavity.
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